Mwanzo000105 • KRX
add
Yuhan Corp Preference Shares
Bei iliyotangulia
₩ 98,600.00
Bei za siku
₩ 96,100.00 - ₩ 98,600.00
Bei za mwaka
₩ 60,900.00 - ₩ 207,000.00
Thamani ya kampuni katika soko
8.71T KRW
Wastani wa hisa zilizouzwa
elfu 7.20
Uwiano wa bei na mapato
102.22
Mgao wa faida
0.52%
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (KRW) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 496.10B | 13.49% |
Matumizi ya uendeshaji wa biashara | 158.12B | 25.16% |
Mapato halisi | -11.51B | -113.43% |
Kiwango cha faida halisi | -2.32 | -111.84% |
Mapato kwa kila hisa | -154.00 | -113.90% |
EBITDA | 4.68B | -73.81% |
Asilimia ya kodi ya mapato | 45.58% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (KRW) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 330.70B | 2.70% |
Jumla ya mali | 2.94T | 4.61% |
Jumla ya dhima | 791.38B | 11.20% |
Jumla ya hisa | 2.15T | — |
hisa zilizosalia | 75.00M | — |
Uwiano wa bei na thamani | 3.52 | — |
Faida inayotokana na mali | -1.01% | — |
Faida inayotokana mtaji | -1.21% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (KRW) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -11.51B | -113.43% |
Pesa kutokana na shughuli | 53.53B | -8.74% |
Pesa kutokana na uwekezaji | -19.08B | 65.62% |
Pesa kutokana na ufadhili | 37.54B | 38.14% |
Mabadiliko halisi ya pesa taslimu | 76.62B | 192.15% |
Mtiririko huru wa pesa | -3.16B | 85.62% |
Kuhusu
Yuhan Corporation is a South Korean pharmaceutical and chemical company headquartered in Daebang-dong, Dongjak-gu, Seoul. It was established in 1926 by New Il-han and has been listed on the Korea Stock Exchange since 1962. Yuhan is one of the top Korean pharmaceutical companies, along with Celltrion, Samsung Biologics, GC Pharma, and Hanmi Pharmaceutical. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1926
Tovuti
Wafanyakazi
1,994
